Integra LifeSciences
Manufacturing · New Jersey, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
311 Enterprise Dr, Plainsboro, New Jerse...Phone Number
(609) 275-0500Website
www.integralife.comRevenue
$1.6 BillionStock Symbol
IARTIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
2
2
2
2
1
About Integra LifeSciences
Founded in 1989 and headquartered in Princeton, New Jersey, Integra LifeSciences is a medical technology company that develops and manufactures surgical instruments, neurosurgical devices, and advanced wound care and tissue repair products. Through its Codman Specialty Surgical and Tissue Technologies segments, the company serves neurosurgeons, neurocritical care teams, ENT specialists, plastic and reconstructive surgeons, and general surgeons. Its portfolio includes neurosurgical tools and systems such as dural repair products, cerebrospinal fluid management devices, intracranial monitoring equipment, and cranial stabilization devices, as well as surgical headlamps and general surgical instruments. Integra also provides specialized solutions for acute and chronic wound management, including burns and diabetic foot ulcers, and offers products for soft tissue, bone, nerve, and tendon repair. In ear, nose, and throat care, the company supplies instrumentation, balloon technologies for siRead more
Integra LifeSciences Org Chart
AC
Corporate Vice President, Business Developmen...
LL
Vice President, Tissue Technologies Strategy,...
TM
Vice President, Sales, Neurosurgery
MP
Vice President, Corporate Development
RF
Vice President, Commercial Sales Operations
RC
Vice President, Sales
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Integra LifeSciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Integra LifeSciences has new funding data
Earning: See what the market has to say on Integra LifeSciences recently announced quarterly report
Click to see if Integra LifeSciences had a recent Job posting/layoffs
Product Launch: Get notified when Integra LifeSciences launches new products
Integra LifeSciences, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Integra LifeSciences has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Integra LifeSciences
Check out if Integra LifeSciences is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Integra LifeSciences as Masked Content
Find 3 more new buyers
Compare Similar Companies to Integra LifeSciences
Compare insights from companies similar to Integra LifeSciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Integra LifeSciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Integra LifeSciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Integra LifeSciences.
Integra LifeSciences Tech Stack
A closer look at the technologies used by Integra LifeSciences
See more technologies
Most Recent Scoops
Pain Point
Integra LifeSciences is experiencing operational disruption at its Cincinnati manufacturing site following flooding in the area. Based on its assessment of available distribution center inventory, secondary supply sources, and insurance coverage, Integra LifeSciences does not expect the event to have a material impact on its revenue or EPS guidance for 2026.
Logistics / Supply Chain, Manufacturing Operations
Earnings
Integra LifeSciences has reported net debt of $1.6 billion as of June 30, 2026, with a consolidated total leverage ratio of 4.1 times, within the current maximum allowable leverage of 5 times and down from 4.5 times at year-end. Total liquidity stood at approximately $496 million, including approximately $274 million in cash and short-term investments, with the remainder available under the revolving credit facility, and the company expects to approach the upper end of its target leverage range of 2.5 to 3.5 times by the end of 2026.
Business Finance, Finance, Financial Operations, Financing & Debt
Hiring Plans
Integra LifeSciences has more open roles in Operations than it has had at any time in the past 9 months with an increased focus on technologies like Assembled, and experience with Oracle E-Business Suite, FedEx, Oracle Enterprise Resource Planning, and Directly. Areas of expertise include: Batch Mixing, Vacuum Pumps, Resource Allocation, User Feedback, Visual Inspections, Production Process, and Preventive Maintenance.
Hiring Plans
Earnings
Integra LifeSciences has reported a gross margin of 61.3% for Q2 2026, up approximately 60 basis points from 60.7% in the prior year, reflecting manufacturing efficiencies and lower remediation spending. Adjusted EBITDA margin was 18.7%, up approximately 160 basis points versus 17.1% in Q2 2025, with cash flows from operations totaling $22.8 million and capital expenditures of $12.3 million for the quarter.
Earnings, Business Finance, Finance, Manufacturing Operations
Earnings
Earnings, Spending/Investment, Forecasting, Finance, Financial Operations
Integra LifeSciences News & Media
Integra LifeSciences Holdings Corporation (IART) Q2 2026 Earnings Call Transcript
Integra LifeSciences Holdings Corporation (IART) Q2 2026 Earnings Call July 29, 2026 8:30 AM EDTCompany ParticipantsChristopher Ward - Senior Director of...Integra LifeSciences Q2 Earnings Call Highlights
Integra LifeSciences (NASDAQ:IART) reported second-quarter 2026 revenue of $419 million, up 0.8% on a reported basis and 0.7% organically from a year earlier, as improving supply reliability and operational execution supported results. Adjusted earnings per share rose 24% year over year to $0.56, exIntegra LifeSciences Reports Second Quarter 2026 Financial Results
PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2026.Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026
PRINCETON, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2026 financial results on Wednesday, July 29, 2026, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Integra LifeSciences
Sign Up For FreeTo access detailed company insights
Founded in 1989 and headquartered in Princeton, New Jersey, Integra LifeSciences is a medical technology company that develops and manufactures surgical instruments, neurosurgical devices, and advanced wound care and tissue repair products. Through its Codman Specialty Surgical and Tissue Technologies segments, the company serves neurosurgeons, neu... Read More
